/Investor DB

iGlobe Partners — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

C2i Genomicsc2i-genomics.comin𝕏Apr 2021 · $100MAcquired

C2i Genomics develops a whole-genome sequencing platform that uses AI algorithms to build patient-specific cancer signatures for detecting minimal residual disease (MRD) and monitoring cancer.

AI & Machine LearningBiotechDigital HealthHealthtechNew York, US

Asaf Zviran(Founder)inEzra Sofer(Executive Officer, Director)

BoardEli Casdin(Director)inAlex Parker(Director)Shaun Rodriguez(Director)in

Co-investorsLionBirdNat TurnerNFXCasdin CapitalSection 32

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.